<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Pharmababble - Latest Comments in GlaxoSmithKline Buys Sirtris for $720M</title><link>http://pharmababble.disqus.com/</link><description>Stream of consciousness pharmaceuticals business development</description><language>en</language><lastBuildDate>Sat, 24 Jan 2009 11:32:12 -0000</lastBuildDate><item><title>Re: GlaxoSmithKline Buys Sirtris for $720M</title><link>http://www.pharmababble.com/glaxosmithkline-buys-sirtris-for-720m/#comment-5516956</link><description>Would be interested see the updates on this thing, thanks.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Skin </dc:creator><pubDate>Sat, 24 Jan 2009 11:32:12 -0000</pubDate></item><item><title>Re: GlaxoSmithKline Buys Sirtris for $720M</title><link>http://www.pharmababble.com/glaxosmithkline-buys-sirtris-for-720m/#comment-5517074</link><description>As far as I know, there are no updates.  No new trials and no change in&lt;br&gt;status for preclinical compounds.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">TheEben</dc:creator><pubDate>Sat, 24 Jan 2009 10:46:21 -0000</pubDate></item><item><title>Re: GlaxoSmithKline Buys Sirtris for $720M</title><link>http://www.pharmababble.com/glaxosmithkline-buys-sirtris-for-720m/#comment-5014264</link><description>...I absolutely agree that the deal is utter nonsense and probably some some GSK's  manager self-promoting idea to keep GSK at the "forefront" of science...the only things really accomplished were some venture capitalists no doubt cleaned up and the odds that we'll all will be paying more for GSK drugs have increased substantially...what's really disgusting is thinking about what 750 million dollars COULD have  accomplished for healthcare in third world countries.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">razormd</dc:creator><pubDate>Tue, 29 Apr 2008 23:22:45 -0000</pubDate></item></channel></rss>